All studies
RecruitingOBSERVATIONAL

VITUS Post-Market Registry

This study, called the VITUS Post-Market Registry, is for people with a condition called peripheral arterial disease (PAD), where arteries in the legs become narrowed or blocked. Doctors are using a special balloon with a drug coating, called the VITUS catheter, to help open up these arteries. This study aims to gather information on how well this device works and how safe it is in real-world use over a longer period. It's collecting data from patients who are already being treated with this device as part of their usual care in various hospitals across Europe. The study helps doctors understand the long-term effects of this treatment.

At a glance

Status
Recruiting
Sponsor
OrbusNeich
Enrolment target
284
Start
22 May 2025
Estimated completion
01 Apr 2029

What is this study about?

This study is called the VITUS Post-Market Registry, and it's designed to learn more about a treatment for a common condition called peripheral arterial disease, or PAD. If you have PAD, it means the arteries in your legs have become narrowed or blocked, reducing blood flow. This can cause pain, especially when walking, and other problems.

Doctors are using a special device called the VITUS peripheral drug-coated dilatation catheter to help open up these blocked arteries. This catheter is a balloon that is inserted into the artery and inflated. The balloon has a special coating that delivers a drug to the artery wall, which helps prevent it from narrowing again. This study is collecting information from patients who are already being treated with this device as part of their routine care.

The main goal is to check how safe and effective the VITUS catheter is over several years when used in everyday medical practice. By gathering this real-world data from many patients across different hospitals, doctors can get a much clearer picture of its long-term benefits.

Key takeaways

  • This study collects real-world information on a specific device for blocked leg arteries.
  • It aims to understand the long-term safety and how well the device works.
  • You would receive standard treatment; the study only observes and collects data.
  • Participation involves follow-up appointments (phone or in-person) over three years.
  • Your contribution helps improve care for future patients with similar conditions.

Who may be eligible?

This study is looking for patients who are already receiving treatment for blocked arteries in their legs using the VITUS drug-coated balloon, as decided by their doctor. The area of the artery being treated needs to be a certain size and length that matches what the balloon is designed for. Your doctor will make sure this applies to you.

However, some people might not be able to join. This includes if there's a high chance you wouldn't be able to attend all the follow-up appointments, or if you're already involved in another study that checks how your leg arteries are doing. Also, if a doctor thinks your life expectancy is less than a year, or if the artery blockage is still quite severe after an initial treatment, you wouldn't be able to take part. Of course, you also can't join if you simply don't want to.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you having a procedure for blocked leg arteries using the VITUS drug-coated balloon?
  2. Is your doctor recommending this specific treatment for you?
  3. Can you commit to attending follow-up appointments over the next three years?
  4. Are you NOT currently part of another similar medical device study?
  5. Have you discussed this with your doctor and not refused to participate?
Answer every question to see your result.

What does participation involve?

If you take part in this registry, you won't be given any new or experimental treatment — you'll be receiving the VITUS drug-coated balloon as part of your standard medical care, just as your doctor would normally recommend. The main part of your participation involves doctors collecting information about your health and the treatment outcome. This includes data right after your procedure, then a series of follow-up checks.

These follow-up checks happen at 30 days, 6 months, 12 months, 24 months, and 36 months after your procedure. These can be done either through a phone call or during a planned hospital visit, whatever is easiest and most appropriate. The total duration of your participation in the registry would be three years.

Potential risks and benefits

Taking part in this study doesn't involve any new or additional risks beyond the standard procedure you'd be having for your blocked arteries. The potential benefit is that by sharing your health information, you're helping doctors understand more about how the VITUS device works in the long term for people like you. This information can improve future care for other patients. You always have the right to withdraw from the registry at any time, without it affecting your medical care.

Locations (13)

  • AZORG
    Verified postcode
    Aalst, Belgium· Recruiting
  • AZ Sint-Blasius
    Verified postcode
    Dendermonde, Belgium· Recruiting
  • ZOL Genk
    Verified postcode
    Genk, Belgium· Recruiting
  • AZ Groennge
    Verified postcode
    Kortrijk, Belgium· Recruiting
  • RZ Heilig Hart Tienen
    Verified postcode
    Tienen, Belgium· Recruiting
  • AZ Jan Portaels
    Verified postcode
    Vilvoorde, Belgium· Recruiting
  • Klinikum Lippe Detmold
    Verified postcode
    Detmold, Germany· Recruiting
  • SRH Klinikum Karlsbad-Langensteinbach GmbH
    City only
    Karlsbad, Germany· Recruiting
  • Singapore General Hospital
    Verified postcode
    Singapore, Singapore· Recruiting
  • Hospital Universitario de Cabueñes
    Verified postcode
    Gijón, Spain· Recruiting
  • Hospital General de Granollers
    Verified postcode
    Granollers, Spain· Recruiting
  • Complejo Hospitalario Universitario de Ourense
    Verified postcode
    Ourense, Spain· Recruiting

Common questions

What is Peripheral Arterial Disease (PAD)?

PAD is a condition where arteries in your legs get narrowed or blocked, reducing blood flow. This can cause pain, especially when walking.

What is the VITUS drug-coated balloon?

It's a special balloon used during an artery-opening procedure. It has a drug on its surface that helps prevent the artery from narrowing again.

Will I get special treatment in this study?

No, you will receive the same treatment your doctor would normally recommend for your condition. The study just collects information about it.

How long will I be followed up?

You will be followed up for three years after your procedure, with checks at specific times like 30 days, 6 months, and annually.

Can I leave the study if I change my mind?

Yes, you can choose to stop participating in the registry at any time, and it won't affect your medical care.

How to find out more

Jenny Chong, BS

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "VITUS Post-Market Registry…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.